Tissue specific induction of cytochrome P450 (CYP) 1A1 and 1B1 in rat liver and lung following in vitro (tissue slice) and in vivo exposure to benzo( a)pyrene

• Published in: Toxicology in vitro Vol. 20; no. 4; pp. 426 - 438
• Main Authors: Harrigan, Jeanine A., McGarrigle, Barbara P., Sutter, Thomas R., Olson, James R.
• Format: Journal Article
• Language: English
• Published: England Elsevier Ltd 01.06.2006
• Subjects: Animals; Aryl Hydrocarbon Hydroxylases - biosynthesis; Aryl Hydrocarbon Hydroxylases - genetics; Benzo( a)pyrene; Benzo(a)pyrene - toxicity; Biotransformation; Carcinogens - toxicity; CYP1A1; CYP1B1; Cytochrome P-450 CYP1A1 - biosynthesis; Cytochrome P-450 CYP1A1 - genetics; Cytochrome P-450 CYP1B1; Dose-Response Relationship, Drug; Enzyme Induction; Gene Expression - drug effects; In Vitro Techniques; Injections, Intraperitoneal; Liver - drug effects; Liver - enzymology; Liver - pathology; Liver slice; Lung - drug effects; Lung - enzymology; Lung - pathology; Lung slice; Male; Polychlorinated Dibenzodioxins - toxicity; Rats; Rats, Sprague-Dawley; RNA, Messenger - metabolism; CYP1A1; CYP1B1; Benzo( a)pyrene; Lung slice; Liver slice
• ISSN: 0887-2333; 1879-3177
• DOI: 10.1016/j.tiv.2005.08.015

Cytochrome P-450s (CYPs) detoxify a wide variety of xenobiotics and environmental contaminants, but can also bioactivate carcinogenic polycyclic aromatic hydrocarbons, such as benzo( a)pyrene (BaP), to DNA-reactive species. The primary CYPs involved in the metabolism and bioactivation of BaP are CYP1A1 and CYP1B1. Furthermore, BaP can induce expression of CYP1A1 and CYP1B1 via the aryl hydrocarbon receptor. Induction of CYP1A1 and CYP1B1 by BaP in target (lung) and non-target (liver) tissues was investigated utilizing precision-cut rat liver and lung slices exposed to BaP in vitro. Tissue slices were also prepared from rats pretreated in vivo with 2,3,7,8-tetrachlorodibenzo- p-dioxin (TCDD) to induce expression of CYP1A1 and CYP1B1. In addition, in vivo exposure studies were performed with BaP to characterize and validate the use of the in vitro tissue slice model. In vitro exposure of liver and lung slices to BaP resulted in a concentration-dependent increase in CYP1A1 and CYP1B1 mRNA and protein levels, which correlated directly with the exposure-related increase in BaP-DNA adduct levels observed previously in the tissue slices [Harrigan, J.A., Vezina, C.M., McGarrigle, B.P., Ersing, N., Box, H.C., Maccubbin, A.E., Olson, J.R., 2004. DNA adduct formation in precision-cut rat liver and lung slices exposed to benzo( a)pyrene. Toxicological Sciences 77, 307–314]. Pretreatment of animals in vivo with TCDD produced a marked induction of CYP1A1 and CYP1B1 expression in the tissue slices, which was similar to the levels of CYP1A1 and CYP1B1 mRNA achieved in liver and lung following in vivo treatment with BaP. Following in vitro exposure to BaP, the levels of CYP1A1 were greater in the lung than the liver, while following all exposures (in vitro and in vivo), the levels of CYP1B1 mRNA were greater in lung tissue compared to liver. The higher expression of CYP1A1 and CYP1B1 in the lung was associated with higher levels of BaP-DNA adducts in the lung slices (Harrigan et al.’s work) and together, these results may contribute to the tissue specificity of BaP-mediated carcinogenesis.